We generated a claudin-4-specific CAR construct and validated its antigen specificity in vitro using SU86.86 cells (claudin-4+) and H522 lung cancer cells (claudin-4-) (Figure 6A). This evidence concerns the gene CLDN4 and lung carcinoma.